4
Changes in Ownership
Propanc Biopharma, Inc. Filed Acc 0001493152-21-020759
Chief Scientific Officer acquired 3,420,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kenyon Julian Norman Chief Scientific Officer | 2021-08-17 | Grant or award | +3,420,000 | 3,420,005 | D |
Loading xslF345X03/ownership.xml…